Avricore Health Inc (AVCR.V) has seen a remarkable surge, gaining over 18% in just one trading day.
In a notable performance on the TSX Venture Exchange, Avricore Health Inc's stock price jumped by 18.18%, closing at CA$0.07. This surge comes amid ongoing developments in the company's expansion efforts and strategic initiatives.
Investor takeaway: Investors are responding positively to Avricore's strategic moves, particularly its focus on expanding the HealthTab™ network in the UK, which may enhance its market presence and revenue potential.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
-8.33%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
136.8%
Annualized
90-Day Vol
113.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.08 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Stock Surges 18.18% in One Day
Avricore Health Inc's stock price increase reflects growing investor interest, possibly driven by expectations surrounding its expansion plans and recent financing activities.
Bull case
The recent financing efforts and strategic roadmap for UK expansion could lead to more pharmacies adopting Avricore's HealthTab™ platform. This growth potential might drive revenue up and boost investor confidence.
Bear case
Despite the positive momentum, the lack of immediate news or catalysts supporting the price increase raises questions about sustainability. Given the company's relatively small market cap of CA$6.95 million, any fluctuations could be significant.
Recent Performance Highlights
Avricore Health Inc's stock price rose by 18.18% in the last trading session, closing at CA$0.07. This surge is a significant indicator of investor sentiment, particularly as the company continues to focus on expanding its HealthTab™ platform in the UK.
Strategic Expansion Plans
The recent financing of CA$1.254 million aims to support Avricore's expansion of the HealthTab™ network. This strategic move is expected to enhance the company's market presence and could lead to increased revenue as the platform gains traction in community pharmacies.
Investor Sentiment and Market Outlook
While the current stock performance is promising, investors should remain cautious. The company's market cap of CA$6.95 million suggests that any fluctuations could be pronounced, and the sustainability of this price increase will depend on the successful execution of its expansion strategy.
Advertisement
